Delivery Order SPE2DB22D2108-SPE2DB25FU5VL
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,352.39 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xifaxan 550 mg tablets (60-count packaging). This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $12,991.41 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a competitive delivery order valued at $4,651.90 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, using firm fixed pricing with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $4,215.61 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award involved no set-aside designation, indicating it was competitively awarded through open competition. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed price contract valued at $12,267.73. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The ultimate completion date...
- The Defense Logistics Agency awarded a $15,832.21 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of April 25, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) under a firm fixed-price contract with a ceiling value of $13,089.77 and an ultimate completion date of September 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,867.95 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,249.80 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $17,556.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60-tablet bottles of Xifaxan 550 mg on September 12, 2025, with a completion date of September 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...